CD4+, but not CD8+, T cells from mammary tumor-bearing mice have a down-regulated production of IFN-γ: Role of phosphatidyl serine

Journal of Immunology

Volumn 160, Issue 6, 1998, Pages 2735-2741

  Cheng, Xiaofang ^a   Lopez, Diana M ^a,b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST ADENOCARCINOMA; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HELPER CELL; IMMUNOREGULATION; INTERFERON PRODUCTION; LYMPHOCYTIC INFILTRATION; METHYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DNA METHYLATION; DOWN-REGULATION; FEMALE; INTERFERON TYPE II; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; PHOSPHATIDYLSERINES; RNA, MESSENGER;

EID: 0032520766     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Johnson, H. M. 1983. Interferon and host defense system. Adv. Exp. Med. Biol. 162:105.
2. Friedman, R. M., and S. N. Vogel. 1983. Interferons with special emphasis on the immune system. Adv. Immunol. 34:97.
3. Young, H. A., and K. J. Hardy. 1990. Interferon-γ: producer cells, activation stimuli, and molecular genetic regulation. Pharmacol. Ther. 45:137.
4. Dalton, D. K., S. Pitts-Meek, S. Keshar, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ gene. Science 259:1739.
5. Paul, R. D., R. Padmahabhan, and D. M. Lopez. 1984. Characterization of the cells mediating an innocent bystander cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice. Cancer Res. 44:4480.
6. Paul, R. D., A. Ghaffar, M. M. Sigel, V. Charyulu, and D. M. Lopez. 1981. Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters. Anticancer Res. 1:63.
7. Sigel, M. M., D. M. Lopez, and G. Ortiz-Muniz. 1976. In vitro immune responses to viral and tumor antigens in murine breast cancer. Cancer Res. 36:748.
8. Sotomayor, E. M., X. F. Cheng, Y.-X. Fu, A. Hawkins, C. Calderon-Higginson, and D. M. Lopez. 1993. Impaired activation of tumoricidal function in macrophages from mammary tumor bearers: the role of IFN-γ. Int. J. Oncol. 3:719.
9. Calderon, C., Z.-H. Huang, D. A. Gage, E. M. Sotomayor, and D. M. Lopez. 1994. Isolation of nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine. J. Exp. Med. 180:945.
10. Watson, G. A., Y.-X. Fu, and D. M. Lopez. 1991. Splenic macrophages from tumor bearing mice coexpressing Mac-1 and Mac-2 antigens exert immunoregulatory functions via distinct mechanisms. J. Leukocyte Biol. 49:126.
11. Handel-Fernandez, M. E., X. Cheng, L. M. Herbert, and D. M. Lopez. 1997. Downregulation of IL-2, not a shift from a Th1 to Th2 phenotype, is responsible for impaired IFN-γ production in tumor bearing mice. J. Immunol. 158:280.
12. Lopez, D. M., M. Lopez-Cepero, G. A. Watson, A. Ganju, E. Sotomayor, and Y.-X. Fu. 1991. Modulation of the immune system by mammary tumor-derived factors. Cancer Invest. 9:643.
13. Fu, Y.-X., G. Watson, J. J. Jimenez, Y. Wang, and D. M. Lopez. 1990. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Cancer Res. 50:227.
14. Medina, D., and K. B. DeOme. 1969. Response of hyperplastic alveolar nodule outgrowth line D1 to mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation acting singly and in combination. J. Natl. Cancer Inst. 42:303.
15. Ly, I. A., and R. J. Mishell. 1974. Separation of mouse spleen cells by passage through columns of Sephadex G-10. J. Immunol. Methods 5:239.
16. Singer-Sam, J., M. Grant, J. M. LeBon, K. Okuyama, V. Chapman, M. Monk, and A. D. Riggs. 1990. Use of a HpaII-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation. Mol. Cell. Biol. 10:4987.
17. Herman, J. G., J. R. Graff, S. Myohanen, D. B. Nelkin, and S. B. Baylin. 1996. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93:9821.
18. Ghosh, P., K. L. Komschlies, M. Cippitelli, D. L. Longo, J. Subleski, J. Ye, A. Sica, H. A. Young, R. H. Wiltrout, and A. C. Ochoa. 1995. Gradual loss of T-helper populations in spleens of mice during progressive tumor growth. J. Natl. Cancer Inst. 87:1478.
19. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348.
20. Fitch, F. W., M. D. McKisic, D. W. Lancki, and T. F. Gajewski. 1993. Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11:29.
21. + T cell clones. J. Immunol. 141:849.
22. Kelso, A. 1995. Th1 and Th2 subsets: paradigms lost? Immunol. Today 16:374.
23. Ferrik, D. A., M. D. Schrenzel, T. Mulvannia, B. Heich, W. G. Ferlin, and H. Lepper. 1995. Differential production of interferon-γ and interleukin-4 in response to Th1- and Th2-stimulating pathogens by γδ T cell in vivo. Nature 373:255.
24. Carter, L. L., and R. W. Dutton. 1996. Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr. Opin. Immunol. 8:336.
25. Clerici, M., and G. M. Shearer. 1993. A Th1→Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14:107.
26. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227.
27. Mocci, S., and R. L. Coffman. 1995. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J. Immunol. 154:3779.
28. Tancini, G., S. Baini, R. Rescaldani, G. Fiorelli, S. Vivani, and P. Lissoni. 1990. Analysis of T helper and suppressor lymphocyte subsets in relation to the clinic stage of solid neoplasms. Oncology 47:381.
29. Waldman, H. 1977. Conditions determining the generation and expression of T helper cells. Immunol. Rev. 35:121.
30. Assenmacher, M., J. Schmitz, and A. Redbrush. 1994. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-γ and in interleukin-4 expressing cells. Eur. J. Immunol. 24:1097.
31. Bucy, R. P., G. Panoskaltsis-Mortari, G. Huang, J. Li, L. Karr, M. Ross, J. M. Rusell, K. M. Murphy, and C. T. Weaver. 1994. Heterogeneity of single cell cytokine gene expression in clonal T cell populations. J. Exp. Med. 180:1251.
32. + T lymphocytes during contact sensitivity. J. Immunol. 158:2567.
33. Melvin, A. J., M. E. McGurn, S. J. Bort, S. J. Gibson, and D. B. Lewis. 1995. Hypomethylation of the interferon-γ gene correlates with its expression by primary T-lineage cells. Eur. J. Immunol. 25:426.
34. Fukunaga, R., M. Matsuyama, H. Okamura, K. Nagata, S. Nagata, and Y. Sokawa. 1986. Undermethylation of interferon-γ gene in human T cell lines and normal T lymphocytes. Nucleic Acids Res. 14:4421.
35. Young, H. A., P. Ghosh, J. Ye, J. Lederer, J. R. Gerard, L. Penix, C. B. Wilson. A. J. Melvin, M. E. McGurn, D. B. Lewis, and D. D. Taub. 1994. Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-γ gene. J. Immunol. 153:3603.
36. Ye, J., M. Cippitelli, L. Dorman, J. R. Ortaldo, and H. A. Young. 1996. The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol. Cell. Biol. 16:4744.
37. Brown, D. A., K. L. Kondo, S. Wong, and D. J. Diamond. 1992. Characterization of nuclear protein binding to the interferon-γ promoter in quiescent and activated human T cells. Eur. J. Immunol. 22:2419.
38. Ciccarone, V. C., J. Chrivia, K. J. Hardy, and H. A. Young. 1990. Identification of enhancer-like elements in human IFN-γ genomic DNA. J. Immunol. 144:725.
39. Lewis, J., R. R. Meehan, W. J. Henzel, I. Maurer-Rogt, P. Jeppesen, H. Klein, and A. Bird. 1992. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69:905.
40. Ducatenzeiler, A., and J. Menezes. 1988. Human gamma interferon induction by staphylococcal protein A: effector cells, kinetics and the effect of prostaglandin, indomethacin, ibuprofen, and aspirin. Int. J. Immunopharmacol. 10:81.
41. Ivashleiv, L. B., A. Ayres, and L. M. Glimeber. 1994. Inhibition of IFN-gamma induction of class II MHC genes by cAMP and prostaglandins. Immunopharmacology 27:67.
42. Nicoletti, G., C. De Giovanni, P.-L. Lollini, G. P. Bagnara, K. Scotlandi, L. Landuzzi, B. Del Re, G. Zauli, G. Prodi, and P. Nanni. 1989. In vivo and in vitro production of hemopoietic colony-stimulating activity by murine cell lines of different origin: a frequent finding. Eur. J. Cancer Clin. Oncol. 25:1281.
43. Takeda, K., K. Hatakeyama, Y. Tsuchiya, H. Rikiishi, and K. Kumagai. 1991. A correlation between GM-CSF gene expression and metastases in murine tumors. Int. J. Cancer 47:413.
44. Tsuchiya, Y., R. Igarashi, M. Suzuki, and K. Kumagai. 1988. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J. Immunol. 141:699.
45. Schmitter, D., B. Lauber, B. Fagg, and R. A. Stahel. 1992. Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature. Int. J. Cancer 51:296.
46. DiNapoli, M. R., C. L. Calderon, and D. M. Lopez. 1996. The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduced expression of the inducible nitric oxide synthase gene. J. Exp. Med. 183:1323.
47. DiNapoli, M. R., C. L. Calderon, and D. M. Lopez. 1997. Phosphatidyl serine is involved in the reduced rate of transcription of the inducible nitric oxide synthase gene in macrophages from tumor-bearing mice. J. Immunol. 158:1810.
48. Brunda, M. J. 1994. Interleukin-12. J. Leukocyte Biol. 55:280.
49. Gerosa, F., C. Paganin, D. Peritti, F. Paiola, M. T. Scapoli, M. Aste-Ameaga, I. Frank, and G. Trinchieri. 1996. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10. J. Exp. Med. 183:2559.